Publication | Closed Access

Mometasone furoate nasal spray increases the number of minimal-symptom days in patients with acute rhinosinusitis

AsthmaAllergyAllergy MedicineAcute RhinosinusitisAllergic RhinitisMedicineAllergic RhinoconjunctivitisMinimal-symptom Days